Johannes Jacob Pieter Kastelein, Chief Scientific Officer: NewAmsterdam Pharma NAMS Sell · Filed 03/09

Trade details

Type: Insider sale
Amount: $3,165,350.1
Shares · price: 104,467 sh · $30.30 a share
Held after: 69,302 sh
Stock: NewAmsterdam Pharma NAMS
Person: Johannes Jacob Pieter KasteleinChief Scientific Officer
Trade date: 26/03/05
Filed: 26/03/09
Days to filing: 4 days

Sold 60.1% of holdings

Share of holding sold: 60.1%

NewAmsterdam Pharma trades, last 26 weeks

What else happened in NewAmsterdam Pharma around then

Filed or reported within 30 days of the trade day · 02/03~04/04

Johannes Jacob Pieter Kastelein's recent trades

Johannes Jacob Pieter KasteleinChief Scientific Officer
Planned sale10b5-1 planNewAmsterdam Pharma
Planned sale10b5-1 plan
NewAmsterdam Pharma
NAMS
$3.5M
125,000 sh
$3.5M
Filed 08/24
Traded 08/24
Johannes Jacob Pieter KasteleinChief Scientific Officer
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$3.1M
101,409 sh
$3.1M
Filed 03/09
Traded 03/09
Johannes Jacob Pieter KasteleinChief Scientific Officer
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$2.9M
94,124 sh
$2.9M
Filed 03/09
Traded 03/06
Johannes Jacob Pieter KasteleinChief Scientific Officer
Planned sale10b5-1 planNewAmsterdam Pharma
Planned sale10b5-1 plan
NewAmsterdam Pharma
NAMS
$9.4M
300,000 sh
$9.4M
Filed 03/05
Traded 03/02
Johannes Jacob Pieter KasteleinChief Scientific Officer
SellNewAmsterdam Pharma
Sell
NewAmsterdam Pharma
NAMS
$1.1M
30,789 sh
$1.1M
Filed 02/24
Traded 02/20